StockData
Verrica Pharmaceuticals Inc. logo

Verrica Pharmaceuticals Inc. (VRCA) stock

VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$3.14−0.06 (-1.88%)

Close on Nov 17, 2026Market cap $53.94MP/E –Yield –

Verrica Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Verrica Pharmaceuticals's price to sales ratio was 2.2× on Nov 11, 2026, against 2.8× a year earlier. Over the last 5 years it ranged from 1.9× to 201.9×, with a median of 14.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.2×−0.3
2025Dec 31, 20252.6×−0.9
2024Dec 31, 20243.5×−92.6
2023Dec 29, 202396.1×+83.5
2022Dec 30, 202212.6×–

More Verrica Pharmaceuticals figures

See a number that looks wrong?